NCAA LSDBi

Division III Proposal - ADM-2023-2

EXECUTIVE REGULATIONS -- ELIGIBILITY FOR CHAMPIONSHIPS -- INELIGIBILITY FOR USE OF BANNED DRUGS -- MEDICAL EXCEPTIONS PER COMMITTEE ON COMPETITIVE SAFEGUARDS AND MEDICAL ASPECTS OF SPORTS POLICY

Convention Year: 2023

Date Submitted: February 22, 2022

Status: Adopted Final

Effective Date: Immediate

Official Notice Number: ADM-2023-2

Source: NCAA Division III Management Council (Committee on Competitive Safeguards and Medical Aspects of Sports).

Proposal Category: Administrative Regulation

Topical Area: Executive Regulations

Intent: To specify that exceptions to the prohibition on use of any substance in a banned-drug class may be provided to a student-athlete, as specified in the policies and procedures of the Committee on Competitive Safeguards and Medical Aspects of Sports.

Administrative: Amend 31.2, as follows:

31.2.3 Ineligibility for Use of Banned Drugs. See Bylaw 18.4.1.5 for the details related to ineligibility for use of banned drugs.

[31.2.3.1 unchanged.]

31.2.3.2 Medical Exceptions. Exceptions to the prohibition on the use of any substance in thea banned-drug classes of stimulants, anabolic agents, alcohol and beta blockers (for rifle only), diuretics and other masking agents, peptide hormones and analogues, hormone and metabolic modulators, and beta-2 agonists may be made by the Board of Governors for those student-athletes with a documented medical history demonstrating the need for regular use of such a drug may be provided to a student-athlete, as specified in the policies and procedures of the Committee on Competitive Safeguards and Medical Aspects of Sports.

[31.2.3.3 through 31.2.3.5 unchanged.]

Rationale: Current legislation does not adequately reflect the original intent or current application of the NCAA medical exception policy, which was designed to ensure that evaluation of exception requests include consideration of emerging, science and medical industry trends. Clarifying in the legislation that banned substance medical exceptions will be managed in accordance with CSMAS created policies and procedures will align the legislative language with the underlying intent and practice, similar to other administrative aspects of the NCAA Drug-Testing Program (e.g., drug-test appeals). This proposal is recommended as noncontroversial legislation, inasmuch as broader consultation and debate are unlikely to improve the proposal in any substantial way, significant disagreement or alternative points of view will not be generated and there does not appear to be a significant impact on existing or proposed legislation.

Budget Impact: None.

Alternate Co-sponsorship Minimums:
  No

Co-sponsorship - Conference:
  None

Co-sponsorship - Institution:
  None

Position Statement(s):
  None

Review History:

Jan 19, 2022:
Approved in Concept - NCAA Division III Management Council (Committee on Competitive Safeguards and Medical Aspects of Sports).
Supplement No. 19
Apr 12, 2022:
Approved in Legislative Format - NCAA Division III Management Council (Committee on Competitive Safeguards and Medical Aspects of Sports).

Convention Vote:
  No Convention Record

Legislative References

Division Number Title
III 31.2.3 Ineligibility for Use of Banned Drugs.
III 31.2.3.2 Medical Exceptions.
References